文献速递急性肾损伤

2'-AMP通过P2X1受体调控肾血管阻力及TNAP的保护作用

Effects and Mechanism of 2'-AMP on Renal Vascular Resistance: Role of P2X1 Receptors.
PubMed 文献 · J Am Soc Nephrol · 2025-12-02

该研究在大鼠肾脏及体外细胞中探讨2'-AMP对肾血管阻力(RVR)的影响,发现2'-AMP经P2X1受体变构调节引起肾血管收缩,而肾脏组织非特异性碱性磷酸酶(TNAP)将其代谢为腺苷从而保护。心脏手术患者尿2'-AMP升高169%并与术后血肌酐升高45%相关。

要点

  • 2'-AMP经P2X1受体正变构调节引起肾血管收缩,TNAP代谢2'-AMP为腺苷而保护。
  • 肾脏TNAP活性降低时2'-AMP诱导的肾血管收缩暴露,P2X1R拮抗剂NF449可抑制。
  • 心脏手术患者尿2'-AMP升高169%,与术后24小时血肌酐峰值升高45%相关。

核心结论

  • 2'-AMP是肾血管收缩剂,TNAP通过代谢2'-AMP为腺苷防止其诱导的肾血管收缩,TNAP活性降低时保护丧失。
  • 2'-AMP诱导的肾血管收缩涉及P2X1受体正变构调节,增强ATP诱导的P2X1R通道开放。

研究设计与样本

  • 研究在大鼠肾脏(体外和体内)进行,并在膜制备和HEK细胞中探讨2'-AMP与P2X1受体的相互作用。
  • 对心脏手术/体外循环(CS-CPB)患者用质谱法评估尿2'-AMP水平。

主要发现

  • 体外经肾动脉灌注2'-AMP迅速代谢为腺苷,不增加RVR;联用TNAP抑制剂(TNAPI)减少2'-AMP代谢,使其触发肾血管收缩。
  • 体内经肾动脉灌注2'-AMP降低RVR(如腺苷);联用TNAPI时2'-AMP增加RVR,且该反应被NF449(P2X1R拮抗剂)抑制。
  • 膜制备中2'-AMP增强3H-αβ-亚甲基-ATP与P2X1R结合;HEK细胞中2'-AMP使αβ-亚甲基-ATP诱导的钙内流加倍。
  • TNAPI+2'-AMP预处理(而非未处理)大鼠中,βγ-亚甲基-ATP引起肾血管收缩。
  • 大鼠R-IRI降低肾脏TNAP活性,TNAP抑制加重R-IRI;CS-CPB患者尿2'-AMP升高169%,与术后24小时血肌酐峰值升高45%相关。

关键数值与推荐

  • CS-CPB患者尿2'-AMP水平升高169%,与术后24小时血清肌酐峰值升高45%相关。

临床怎么用

  • 应避免在肾损伤风险患者中使用具有降低肾脏TNAP活性脱靶效应的药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: 2'-AMP is endogenous and causes renal vasoconstriction in part by allosteric modulation of P2X1 receptors that enhances ATP-induced opening of P2X1 receptor channels. Kidney tissue nonspecific alkaline phosphatase (TNAP) by metabolizing 2'-AMP protects against 2'-AMP-induced renal vasoconstriction, a protection lost when kidney TNAP activity is reduced. Drugs with off-target effects that reduce kidney TNAP activity should be avoided in patients at risk of kidney injury. BACKGROUND: Knockout of 2',3'-cyclic-nucleotide 3'-phosphodiesterse (an enzyme that converts 2',3'-cAMP to 2'-AMP) reduces 2'-AMP production and improves renal perfusion in renal ischemia-reperfusion injury (R-IRI). These findings motivated our hypothesis, herein tested, that 2'-AMP causes renal vasoconstriction. METHODS: The effect of 2'-AMP on renal vascular resistance (RVR) was investigated in rat kidneys, both in vitro and in vivo . 2'-AMP interactions with P2X1 receptors (P2X1Rs) were investigated in membrane preparations and HEK cells. Urinary 2'-AMP levels were assessed in cardiac surgery/cardiopulmonary bypass (CS-CPB) patients using mass spectrometry. RESULTS: In vitro , intra-renal-artery-infused 2'-AMP was rapidly metabolized to adenosine and did not increase RVR. Coadministration of a tissue nonspecific alkaline phosphatase inhibitor (TNAPI) reduced 2'-AMP metabolism, thus enabling 2'-AMP to trigger renal vasoconstriction. In vivo , kidneys rapidly metabolized intra-renal-artery-infused 2'-AMP to adenosine; this was blocked with a TNAPI. In vivo , intra-renal-artery-infused 2'-AMP decreased RVR, as did adenosine. By contrast, when coadministered with a TNAPI, 2'-AMP increased RVR, and this response was inhibited by NF449 (P2X1R antagonist). In membranes, 2'-AMP enhanced 3 H- αβ -methylene-ATP (P2X1R agonist) binding to P2X1Rs, and in HEK cells, 2'-AMP doubled αβ -methylene-ATP-induced (and P2X1R-mediated) calcium influx. In TNAPI+2'-AMP-pretreated, but not naïve, rats, βγ -methylene-ATP (P2X1R agonist) caused renal vasoconstriction. In rats, R-IRI reduced kidney tissue nonspecific alkaline phosphatase (TNAP) activity, and TNAP inhibition worsened R-IRI. In CS-CPB patients, urinary 2'-AMP levels were elevated 169% during CS-CPB and were associated with a 45% increase in peak 24-hour postprocedure serum creatinine. CONCLUSIONS: 2'-AMP is a renal vasoconstrictor; however, TNAP, by metabolizing 2'-AMP to adenosine, protects against 2'-AMP-induced renal vasoconstriction. This protection is lost when TNAP activity is reduced. 2'-AMP-induced renal vasoconstriction involves positive allosteric modulation of P2X1Rs that enhances ATP-induced opening of P2X1R channels. R-IRI reduces kidney TNAP activity, and TNAP inhibition worsens R-IRI outcomes.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Jackson EK, Cheng D, Gillespie DG, et al. Effects and Mechanism of 2'-AMP on Renal Vascular Resistance: Role of P2X1 Receptors. J Am Soc Nephrol. 2025. PMID: 41563396. doi:10.1681/ASN.0000000954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。